Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T15:10:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T15:19:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study record history now shows a new revision labeled v3.7.0, replacing the previous v3.6.6 entry.
    Difference
    0.1%
    Check dated 2026-09-20T20:25:27.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The record history shows a new revision entry v3.6.6 added and the previous revision v3.6.5 removed, indicating a metadata update to the study's version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:37:50.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.5, has been added to the record history, and the previous revision v3.6.4 has been removed, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-08-09T10:59:37.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The study record history shows a new revision entry v3.6.4 added and the previous revision v3.6.3 removed. This updates the version history to reflect the latest change.
    Difference
    0.1%
    Check dated 2026-07-25T18:11:56.000Z thumbnail image

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.